Cancer Letters
Volume 222, Issue 1 , Pages 119-124 , 10 May 2005

Cytotoxicity of xanthopterin and isoxanthopterin in MCF-7 cells

  • Jean L. Lord

      Affiliations

    • Graduate School of Public Health, San Diego State University, San Diego, CA 92182-4162, USA
    • ,
  • Ann de Peyster

      Affiliations

    • Graduate School of Public Health, San Diego State University, San Diego, CA 92182-4162, USA
    • ,
  • P.J.E. Quintana

      Affiliations

    • Graduate School of Public Health, San Diego State University, San Diego, CA 92182-4162, USA
    • ,
  • Robert P. Metzger

      Affiliations

    • Department of Chemistry, San Diego State University, San Diego, CA 92182-1030, USA
    • Corresponding Author InformationCorresponding author. Fax: +1 619 594 4634.

Received 16 March 2004 ,Accepted 2 September 2004.

References 

  1. Nichol CA, Smith GK, Duch DS. Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. Annu. Rev. Biochem. 1985;54:729–764
  2. Kaufman S. New tetrahydrobiopterin-dependent systems. Annu. Rev. Nutr. 1993;13:261–286
  3. Yoneyama Y, Hatakeyama K. Ligand binding to the inhibitory and stimulatory GTP cyclohydrolase I/GTP cyclohydrolase I feedback regulatory protein complexes. Protein Sci. 2001;10:871–878
  4. Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr. Drug Metab. 2002;3:175–187
  5. Birk D, Gansauge F, Gansauge S, Schwarz A, Beger HG. Levels of serum neopterin are increased in pancreatic cancer patients and correlate with the prognosis. Eur. J. Med. Res. 1999;4:156–160
  6. Murr C, Bergant A, Widschwendter M, Heim K, Schrocksnadel H, Fuchs D. Neopterin is an independent prognostic variable in females with breast cancer. Clin. Chem. 1999;45:1998–2004
  7. Trehan S, Moronha JM. Direct correlation between neopterin and excretion of total pteridines in normal controls and cancer subjects. J. Clin. Biochem. Nutr. 1995;19:107–113
  8. Bakir A, Shaykh M, Williams R, Ahmed S, Dunea G. A study of xanthopterin in chronic renal failure. Am. J. Nephrol. 1992;12:224–228
  9. Fukuda A, Muzda T, Gyure WI, Iino T, Harado H, Yakura M, et al. A comparative study of urinary xanthopterin and neopterin in liver diseases. Eur. J. Clin. Chem. Clin. Biochem. 1993;31:129–134
  10. Goldberg M, Gassner F, Merkenschlager M. Altered urinary excretion of pteridines in dogs with various tumors. J. Vet. Med. series A. 1987;34:481–486
  11. Goldberg M, Gassner F, Merkenschlager M. Studies and comparison of urinary pteridine patterns in dogs and cats and their alteration in various neoplasias and virus infections. Pteridines. 1989;1:29–35
  12. Han F, Huynh BH, Shi H, Lin B, Ma Y. Pteridine analysis in urine by capillary electrophoresis using laser-induced fluorescence detection. Anal. Chem. 1999;71:1265–1269
  13. Stea B, Halpern RM, Halpern BC, Smith RA. Urinary excretion levels of unconjugated pterins in cancer patients and normal individuals. Clin. Chem. Acta. 1981;113:231–242
  14. Espinosa Mansilla A, Durán Merás I, Salinas F. Analysis of pteridines and creatine by HPLC with serial fluorimetric and photometric detectors. Chromatographia. 2001;53:510–514
  15. Goldberg M, Koller M. Concentrations and patterns of released pterins of various animal cell cultures. J. Vet. Med. series A. 1991;38:49–53
  16. Stea B, Backlund PS, Berkey PB, Cho AK, Halpern BC, Halpern RM, et al. Folate and pterin metabolism by cancer cells in culture. Cancer Res. 1978;38:2378–2384
  17. Webber S, Nazarbaghi R. The transport of pteridines in CCRF-CEM human lymphoblastic cells. Cancer Chemother. Pharmacol. 1989;23:283–290
  18. Ritter S, Henze M, Anders F. Effect of pteridines on normal and neoplastic cell lines of Xiphophorus. Cell Biol. Intern. Reports. 1988;12:431–442
  19. Saska J, Grzelakowska-Szlabert B, Zielinska ZM. Sensitivity of insect ovarian tissues to various pteridines as tested in tissue culture. J. Insect Physiol. 1972;18:1733–1737
  20. Rubenstein M, Muchnik S, Garber SL, Arruda JAL, Dunea G. Differential effect of xanthopterin and biopterin on cell growth. Int. J. Biochem. 1993;25:1873–1880
  21. Drug Evaluation Branch, Developmental Therapeutics Program (1982) NSC 41836, NSC 91557, NSC 118090. Division of Cancer Treatment, National Cancer Institute, Bethesda, MD.
  22. Kokolis N, Mylonas N, Ziegler I. Pteridine and riboflavine in tumor tissue and the effect of chloroamphenicol and isoxanthopterin. Z. Naturforsch. [B]. 1972;27:292–295
  23. Lewisohn R, Laszlow D, Leuchtenberger R, Leuchtenberger C. The action of xanthopterin on tumor growth. Proc. Soc. Exp. Biol. Med. 1944;56:144–145
  24. Malich G, Markovci B, Winder C. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology. 1997;124:179–192

PII: S0304-3835(04)00714-1

doi: 10.1016/j.canlet.2004.09.009

Cancer Letters
Volume 222, Issue 1 , Pages 119-124 , 10 May 2005

Article Tools

* Image Usage & Resolution